[Skip to Content]
[Skip to Content Landing]

New Insights on COVID-19’s Hyperinflammation in Children

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

A rare, life-threatening hyperinflammatory syndrome that some children develop after coronavirus disease 2019 (COVID-19) is distinct from Kawasaki disease, according to a collaboration among European scientists.

Although most children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have mild or no symptoms, some develop a Kawasaki-like condition called multisystem inflammatory syndrome in children (MIS-C) about 4 to 6 weeks after their infection. To understand why, the investigators studied the immune responses of 41 children with mild COVID-19, 13 others who had MIS-C, and 28 children who were treated for Kawasaki disease before the pandemic.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

A rare, life-threatening hyperinflammatory syndrome that some children develop after coronavirus disease 2019 (COVID-19) is distinct from Kawasaki disease, according to a collaboration among European scientists.

Although most children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have mild or no symptoms, some develop a Kawasaki-like condition called multisystem inflammatory syndrome in children (MIS-C) about 4 to 6 weeks after their infection. To understand why, the investigators studied the immune responses of 41 children with mild COVID-19, 13 others who had MIS-C, and 28 children who were treated for Kawasaki disease before the pandemic.

They found that the MIS-C inflammatory response is distinct from the cytokine storm seen in adults with severe COVID-19 and from hyperinflammation in children with Kawasaki disease. Patients with MIS-C had less interleukin-17A–mediated inflammation and distinct autoantibodies compared with children who had Kawasaki disease. The results lay the groundwork for future studies on the mechanism of MIS-C.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close